Haemonetics Corporation
DE ˙ DB ˙ US4050241003
59,00 € ↑3,00 (5,36%)
2026-06-04
AKTIENPREIS
SecurityDE:HAZ / Haemonetics Corporation
InstitutionFifth Third Bancorp
Latest Disclosed Ownership50,804 shares
Latest Disclosed Value $ 2,863,317
Fifth Third Bancorp reports 12,475.25% increase in ownership of HAZ / Haemonetics Corporation

On May 1, 2026 - Fifth Third Bancorp filed a 13F-HR form disclosing ownership of 50,804 shares of Haemonetics Corporation (DE:HAZ) valued at $2,438,592 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 404 shares of Haemonetics Corporation. This represents a change in shares of 12,475.25% during the quarter. The current value of the position is $2,997,436 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F HAEMONETICS CORP MASS COM 405024100 50,804 50,400 12,475.25 2,863 8,846.88 0.0052
2026-02-02 2025-12-31 13F HAEMONETICS CORP MASS COM 405024100 404 161 66.26 32 190.91 0.0001
2025-11-07 2025-09-30 13F HAEMONETICS CORP MASS COM 405024100 243 -187 -43.49 12 -65.62 0.0000
2025-07-15 2025-06-30 13F HAEMONETICS CORP MASS COM 405024100 430 60 16.22 32 39.13 0.0001
2025-04-15 2025-03-31 13F HAEMONETICS CORP MASS COM 405024100 370 26 7.56 24 -11.54 0.0001
2025-01-21 2024-12-31 13F HAEMONETICS CORP MASS COM 405024100 344 75 27.88 27 23.81 0.0001
2024-10-17 2024-09-30 13F HAEMONETICS CORP MASS COM 405024100 269 -15 -5.28 22 -8.70 0.0001
2024-07-22 2024-06-30 13F HAEMONETICS CORP MASS COM 405024100 284 122 75.31 23 76.92 0.0001
2024-04-23 2024-03-31 13F HAEMONETICS CORP MASS COM 405024100 162 -175 -51.93 14 -53.57 0.0001
2024-01-19 2023-12-31 13F HAEMONETICS CORP MASS COM 405024100 337 -56 -14.25 29 -20.00 0.0001
2023-10-31 2023-09-30 13F HAEMONETICS CORP MASS COM 405024100 393 -1,555 -79.83 35 -78.79 0.0002
2023-07-26 2023-06-30 13F HAEMONETICS CORP MASS COM 405024100 1,948 52 2.74 166 5.77 0.0007
2023-04-24 2023-03-31 13F HAEMONETICS CORP MASS COM 405024100 1,896 39 2.10 157 6.85 0.0007
2023-01-25 2022-12-31 13F HAEMONETICS CORP MASS COM 405024100 1,857 27 1.48 146 8.15 0.0007
2022-10-25 2022-09-30 13F HAEMONETICS CORP MASS COM 405024100 1,830 0 0.00 135 13.45 0.0007
2022-08-04 2022-06-30 13F HAEMONETICS CORP MASS COM 405024100 1,830 30 1.67 119 4.39 0.0006
2022-04-19 2022-03-31 13F HAEMONETICS CORP MASS COM 405024100 1,800 -132 -6.83 114 11.76 0.0005
2022-02-01 2021-12-31 13F HAEMONETICS CORP MASS COM 405024100 1,932 967 100.21 102 50.00 0.0004
2021-10-15 2021-09-30 13F HAEMONETICS CORP MASS COM 405024100 965 -776 -44.57 68 -41.38 0.0003
2021-08-06 2021-06-30 13F HAEMONETICS CORP MASS COM 405024100 1,741 1,605 1,180.15 116 673.33 0.0005
2021-05-07 2021-03-31 13F HAEMONETICS CORP MASS COM 405024100 136 136 15 0.0001
2021-02-16 2020-12-31 13F HAEMONETICS COM 405024100 0 -48 -100.00 0 -100.00
2020-11-09 2020-09-30 13F HAEMONETICS COM 405024100 48 -3,392 -98.60 4 -98.70 0.0000
2020-08-05 2020-06-30 13F HAEMONETICS COM 405024100 3,440 443 14.78 308 3.01 0.0018
2020-05-05 2020-03-31 13F HAEMONETICS COM 405024100 2,997 2,705 926.37 299 779.41 0.0021
2020-02-14 2019-12-31 13F HAEMONETICS COM 405024100 292 0 0.00 34 -8.11 0.0002
2019-11-14 2019-09-30 13F HAEMONETICS COM 405024100 292 0 0.00 37 5.71 0.0002
2019-08-07 2019-06-30 13F HAEMONETICS COM 405024100 292 -67 -18.66 35 12.90 0.0002
2019-05-14 2019-03-31 13F HAEMONETICS COM 405024100 359 0 0.00 31 -13.89 0.0002
2019-02-14 2018-12-31 13F HAEMONETICS COM 405024100 359 -64 -15.13 36 -25.00 0.0003
2018-11-14 2018-09-30 13F HAEMONETICS COM 405024100 423 -56 -11.69 48 11.63 0.0003
2018-08-14 2018-06-30 13F HAEMONETICS COM 405024100 479 0 0.00 43 22.86 0.0003
2018-05-15 2018-03-31 13F HAEMONETICS COM 405024100 479 359 299.17 35 400.00 0.0002
2018-02-14 2017-12-31 13F HAEMONETICS COM 405024100 120 -409 -77.32 7 -70.83 0.0000
2017-11-14 2017-09-30 13F HAEMONETICS COM 405024100 529 401 313.28 24 380.00 0.0002
2017-08-11 2017-06-30 13F HAEMONETICS COM 405024100 128 94 276.47 5 400.00 0.0000
2017-02-13 2016-12-31 13F/A-1 HAEMONETICS COM 405024100 34 0 0.00 1 0.00 0.0000
2017-02-09 2016-12-31 13F HAEMONETICS COM 405024100 34 0 1 0.0000
2016-11-10 2016-09-30 13F HAEMONETICS COM 405024100 34 34 0.00 1 0.0000
2016-05-13 2016-03-31 13F HAEMONETICS COM 405024100 0 -142 -100.00 0 -100.00
2016-02-16 2015-12-31 13F HAEMONETICS COM 405024100 142 2 1.43 5 0.00 0.0000
2015-11-13 2015-09-30 13F HAEMONETICS COM 405024100 140 47 50.54 5 25.00 0.0000
2015-08-14 2015-06-30 13F HAEMONETICS COM 405024100 93 1 1.09 4 0.00 0.0000
2015-05-14 2015-03-31 13F HAEMONETICS COM 405024100 92 92 0.00 4 0.0000
2015-02-13 2014-12-31 13F HAEMONETICS COM 405024100 0 -95 -100.00 0 -100.00
2014-11-17 2014-09-30 13F HAEMONETICS COM 405024100 95 -214 -69.26 3 -72.73 0.0000
2014-08-14 2014-06-30 13F HAEMONETICS COM 405024100 309 0 0.00 11 10.00 0.0001
2014-05-15 2014-03-31 13F HAEMONETICS COM 405024100 309 5 1.64 10 -23.08 0.0001
2014-02-14 2013-12-31 13F HAEMONETICS COM 405024100 304 -938 -75.52 13 -74.00 0.0001
2013-11-14 2013-09-30 13F HAEMONETICS COM 405024100 1,242 924 290.57 50 284.62 0.0005
2013-08-14 2013-06-30 13F HAEMONETICS COM 405024100 318 318 13 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.